Clinical Trial Update: Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia. [NA]

View source ↗

Summary

This update describes ongoing clinical evaluation of KL003 Cell Injection for safety and efficacy in patients with transfusion-dependent beta-thalassemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• KL003 cell injection

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Transfusion-dependent Beta-Thalassemia | NA | Status: ACTIVE_NOT_RECRUITING